Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 2Lymphoid 1Breast 1

Conditions

Breast Neoplasms 3137Triple Negative Breast Neoplasms 514Ovarian Neoplasms 230Colorectal Neoplasms 190Carcinoma, Non-Small-Cell Lung 189Prostatic Neoplasms 184Neoplasms 176Neoplasm Metastasis 164Lung Neoplasms 164Melanoma 118Stomach Neoplasms 114Pancreatic Neoplasms 113Endometrial Neoplasms 107Uterine Cervical Neoplasms 95Squamous Cell Carcinoma of Head and Neck 88Colonic Neoplasms 82Carcinoma, Intraductal, Noninfiltrating 82Head and Neck Neoplasms 81Sarcoma 62Breast Carcinoma In Situ 62Carcinoma, Renal Cell 61Urinary Bladder Neoplasms 60Motor Activity 59Esophageal Neoplasms 58Brain Neoplasms 50Lymphedema 44Breast Cancer Female 41Liver Neoplasms 39Advanced Breast Cancer 39HER2-positive Breast Cancer 38

Interventions

Losartan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Camurati-Engelmann Syndrome × Breast × 1 year × Clear all
NCT05637216 2026-04-24

Losartan to Reduce Radiation Induced Fibrosis in Breast Cancer Patients

Shaw Cancer Center

Phase 2 Recruiting
43 enrolled
Breast

Radiation Fibrosis Syndrome, Breast Neoplasms, Camurati-Engelmann Syndrome, Fibrosis, Inflammation

Data powered by HemOnc (CC BY 4.0) Colophon âš¡